40
Todd Young
Serving in office
Scheduled research active
Main board
Too little promise evidence has been reviewed. Treat this score as provisional.
This profile keeps a lifetime office and promise record. The trust score is designed to stay close to 50 until enough claims and evidence are reviewed.
Breakdown
- Delivered during the term promised: 0 x 1.0
- Delivered in a later elected term: 0 x 0.8
- Partial delivery: 2 x 0.4
- Never delivered: 3 x 0.0
- Disputed claims tracked separately: 0
- Reviewed promises in current record: 5
- Confidence: 29%
- Current claim count: 16
- Current evidence count: 60
Office History
-
U.S. Senator
Indiana · current
Senate service began with the 115th Congress and continues वर्तमान. -
U.S. Senator
Indiana · current
Historical elected offices still need research. -
U.S. Senate re-election campaign
Indiana
Re-election campaign for the Senate seat he already held. -
U.S. Senate campaign
Indiana
Federal campaign for the Senate seat he won in the 2016 election. -
U.S. Representative
Indiana's 9th Congressional District
House service covering three terms. -
U.S. House of Representatives campaign
Indiana's 9th Congressional District
Federal campaign for the House seat he ultimately won in the 2010 election.
- Prohibit federally elected officials and government employees from using insider information to bet on prediction market contracts.
- Ban members of Congress from trading stocks by supporting legislation to prohibit or restrict Congressional stock trading.
- Repeal the Affordable Care Act's 30-hour definition of full-time employment.
- Expand access to outcomes-based financing options for postsecondary education and workforce training while establishing federal consumer protections for participants.
- Cap required payments on outcomes-based financing products at no more than 20 percent of student income and require no payments below a minimum affordability threshold.
- Limit the cost of outcomes-based financing products for students earning at or below 350 percent of the federal poverty level.
- Set clear limits on both the maximum number of payments and the total duration of outcomes-based financing obligations.
- Require standardized disclosures for outcomes-based financing terms and illustrations of how payments vary at different income levels.
- Ensure outcomes-based financing products receive bankruptcy protections and are not subject to heightened standards applied to certain student loans.
- Prevent outcomes-based financing providers from accelerating payment obligations after delinquency or default except in limited cases involving outcomes-based loans.
- Terminate outcomes-based financing obligations when the borrower dies or has a total and permanent disability.
- Clarify the tax treatment of outcomes-based financing products, including protections for low-income students whose obligations are reduced, discharged, or terminated.
- Establish a subscription-style federal payment model for novel antimicrobials that gives developers predictable payments in exchange for access to critical antibiotics.
- Incentivize development of new antibiotics and antifungals targeting dangerous antimicrobial-resistant infections.
- Promote education for health care providers on avoiding overprescription of antibiotics and antifungals to slow antimicrobial resistance.
- Accelerate quantum technology development and real-world applications that are vital to U.S. economic and national security.
Method note
Long term, this app should score against a manually reviewed promise ledger that spans every elected office the candidate has held. The current model uses a Bayesian-style shrinkage step: thin records are pulled back toward 50 so the UI does not overstate certainty.
Claim occurrences, evidence, and future AI adjudications are all designed to store provider and model provenance. Formula version: 0.1.0.